You are the owner of this page.
Edit Page
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Zai Lab Ltd (NQ: ZLAB )

87.54 USD +0.07 (+0.08%)
Official Closing Price Updated: 4:41 PM EDT, Oct 20, 2020 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 171,062
Open 88.05
Bid (Size) 80.00 (1)
Ask (Size) 94.74 (1)
Prev. Close 87.47
Today's Range 86.70 - 89.90
52wk Range 29.43 - 95.52
Shares Outstanding 49,912,570
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
Zai Lab Announces Full Exercise of the Over-allotment Option
From GlobeNewswire News Releases
Zai Lab Announces First Patient Dosed in Greater China in the Global Phase 2/3 MAHOGANY Study of Margetuximab in Gastric and Gastroesophageal Junction Cancer
From GlobeNewswire News Releases

Performance

YTD
+105.40%
+105.40%
1 Month
+19.43%
+19.43%
3 Month
+3.67%
+3.67%
6 Month
+34.88%
+34.88%
1 Year
+166.65%
+166.65%

More News

Read More
Zai Lab Announces First Patient Dosed in China in a Global Phase 3 Study of Retifanlimab in Patients with NSCLC
From GlobeNewswire News Releases
Zai Lab Announces Closing of Hong Kong Secondary Listing
From GlobeNewswire News Releases
Qiming's Portfolio Company Zai Lab Lists on Main Board of HKEX
From PR Newswire
Zai Lab Announces Pricing of Hong Kong Secondary Listing
From GlobeNewswire News Releases
Strange: Bullish ZLAB Analysts Actually See -8.67% Downside
Tags ETFs
From ETF Channel
Phase 3 NORA data of ZEJULA® (niraparib) demonstrate significant PFS benefit, regardless of biomarker status, with an improved safety profile when given with individualized starting dose regimen in Ch
From GlobeNewswire News Releases
Week In Review: $1.5 Billion Total In Week's China Deals
Tags Healthcare Stocks / Equities Pharma/Biotech
From Blogs - TalkMarkets
Week In Review: Zai Lab Completes Second Listing With $761 Million HK IPO
Tags Healthcare Stocks / Equities Pharma/Biotech
From Blogs - TalkMarkets
Week In Review: Illumina Pays $8 Billion To Acquire GRAIL, An Early-Stage Cancer Testing Company
Tags Pharma/Biotech Stocks / Equities Healthcare
From Blogs - TalkMarkets
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.